Financials in USD. Standardized financial statements.
A compact view of how CSPC Pharmaceutical Group Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $25.29B | $28.99B | $34.60B | $30.94B | $27.90B | $24.92B | $22.08B | $20.17B | $15.46B | $12.37B |
| Revenue Growth? | -12.8% | -16.2% | +11.8% | +10.9% | +11.9% | +12.9% | +9.5% | +30.4% | +25.0% | 0.0% |
| Cost of Revenue? | $8.70B | $8.71B | $10.20B | $8.68B | $6.73B | $6.26B | $6.18B | $6.81B | $6.12B | $6.06B |
| Gross Profit? | $16.59B | $20.29B | $24.40B | $22.26B | $21.14B | $18.69B | $15.89B | $13.36B | $9.35B | $6.31B |
| Gross Margin? | +65.6% | +70.0% | +70.5% | +71.9% | +75.8% | +75.0% | +72.0% | +66.3% | +60.4% | +51.0% |
| Operating Expenses? | $12.73B | $14.92B | $16.72B | $15.50B | $14.91B | $13.21B | $11.31B | $9.73B | $5.86B | $3.66B |
| Operating Income? | $3.86B | $5.43B | $7.68B | $6.91B | $6.25B | $5.46B | $4.60B | $4.22B | $3.48B | $2.65B |
| EBITDA? | $5.23B | $6.45B | $8.53B | $8.66B | $7.02B | $7.21B | $4.71B | $5.32B | $4.22B | $3.13B |
| Income Before Tax | $4.68B | $5.58B | $7.39B | $7.72B | $6.85B | $6.39B | $4.63B | $4.50B | $3.47B | $2.64B |
| Income Tax Expense | $906.07M | $1.24B | $1.32B | $1.35B | $1.16B | $1.16B | $891.70M | $835.32M | $685.25M | $522.11M |
| Net Income? | $3.78B | $4.33B | $5.87B | $6.20B | $5.61B | $4.34B | $3.71B | $3.51B | $2.77B | $2.10B |
| EPS? | $1.32 | $1.48 | $2.00 | $2.04 | $1.88 | $1.64 | $1.24 | $1.16 | $0.92 | $0.72 |
| Diluted EPS? | $1.32 | $1.48 | $2.00 | $2.04 | $1.88 | $1.64 | $1.24 | $1.16 | $0.92 | $0.72 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality